Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis.

BMC cancer - 12 Nov 2020

Cao Yinghao, Gu Junnan, Yan Lizhao, Deng Shenghe, Mao Fuwei, Cai Wentai, Li Hang, Liu Xinghua, Wang Jiliang, Wu Ke, Cai Kailin

Abstract excerpt

BACKGROUND: Identifying the mutation status of KRAS is important for optimizing treatment in patients with colorectal cancer (CRC). The aim of this study was to investigate the predictive value of haematological parameters and serum tumour markers (STMs) for KRAS gene mutations. METHODS: The clinical data of patients with colorectal cancer from January 2014 to December 2018 were retrospectively collected, and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Follow-Up Studies

Share to Hematocrit

Share to Predictive Value of Tests

Share to Proto-Oncogene Proteins p21(ras)

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 33183271
DOI: 10.1186/s12885-020-07551-4
PMCID: PMC7659200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The value of haematological parameters and serum tumour markers for predicting KRAS mutations in 784 Chinese colorectal cancer patients: a retrospective analysis.PMID 33183271Read ↗

Serum tumour markers combined with clinicopathological characteristics for predicting MMR and KRAS status in 2279 Chinese colorectal cancer patients: a retrospective analysisSemantic proximity Read ↗

Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia.Semantic proximity Read ↗

Prognostic Value of KRAS Mutations in Colorectal Cancer PatientsSemantic proximity Read ↗

Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients.Semantic proximity Read ↗

A Systematic Review and Meta-analysis on the Occurrence of Biomarker Mutation in Colorectal Cancer among the Asian Population.Semantic proximity Read ↗

Associations of KRAS Mutations and Clinical Characteristics of Colorectal Cancer Patients in Indonesia.Semantic proximity Read ↗

The current understanding on the impact of KRAS on colorectal cancer.Semantic proximity Read ↗

RAS and BRAF genes as biomarkers and target for personalised colorectal cancer therapy: An update.Semantic proximity Read ↗

Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.Semantic proximity Read ↗

KRAS mutation and its association with clinicopathological features of colorectal cancer patients in Africa: a systematic review and meta-analysis.Semantic proximity Read ↗

Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.Semantic proximity Read ↗

KRAS mutations: analytical considerations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.